CD38 and sarcoidosis: In preliminary studies, we have shown that “naive” activated B-lymphocytes (Bm2) with IgD+CD38+ phenotype and the general subpopulation of “naive” B-lymphocytes with CD5−CD27− phenotype was increased in the circulation in patients with sarcoidosis relative to the values of the control group [28].